When someone begins researching transcranial magnetic stimulation for depression in Los Angeles, they quickly encounter a range of terms: standard TMS, accelerated TMS, theta burst, neuronavigation, MRI-guided targeting. Each describes a real difference in how treatment can be planned and delivered, yet it is not always clear what those differences mean for an individual. A consultation is the right place to sort through them. At NeoPsych in Glendale, Dr. Thomas Hughes encourages people to arrive with questions, because a well-informed decision about targeting, scheduling, and follow-up is part of personalized care.
What MRI-Guided TMS Means
TMS uses a magnetic coil placed against the scalp to stimulate a specific area of the brain, most commonly a region of the left dorsolateral prefrontal cortex that is connected to deeper networks involved in mood. Where the coil is placed matters, and there are several ways to find that location.
Traditional Scalp-Based Targeting
The original approach to finding a treatment location relies on anatomical measurements of the head, often with a cap marked to guide coil placement. As our Accelerated TMS page explains, these methods have been a trusted part of TMS since it became available to the public in 2008, and they remain perfectly reasonable. Their limitation is that heads and brains vary, and consistency from session to session can be affected by small changes in position.
3D-Guided Targeting Without MRI
NeoPsych also offers 3D-guided mapping, which does not use an MRI. Instead, it creates an individualized head model for each person so that the coil can be placed at the same angle and location each day. This helps with session-to-session consistency and allows the provider to see if the coil shifts during treatment, without the need for a cap.
Functional Connectivity MRI Guidance
Functional connectivity MRI, often abbreviated fcMRI, uses resting-state brain imaging to look at how regions of the brain communicate with one another. In fcMRI-guided TMS, that information is used to choose a treatment target that is individualized to the person’s own brain. At NeoPsych, a highly trained neuroscientist performs each reading, and the resulting target guides coil placement. The MRI is an optional add-on rather than a requirement, and people with claustrophobia or other reasons to avoid an MRI can still pursue accelerated treatment with other targeting methods.
The Science Behind Personalized Targeting
The idea of individualized targeting grew from research into why some TMS sites appear more effective than others.
Connectivity and Treatment Response
In a 2012 study in Biological Psychiatry, Fox and colleagues analyzed resting-state functional MRI data and found that the clinical effectiveness of different left dorsolateral prefrontal TMS targets reported in prior research was related to how those targets were connected with the subgenual cingulate, a deeper region involved in mood. Sites that were more negatively correlated with that region tended to be associated with better outcomes. This work was foundational, but it was based on connectivity analyses and a small patient cohort rather than a treatment trial.
Recent Clinical Trial Evidence
More recent research has begun to test individualized targeting directly. A randomized, double-blind trial by Li and colleagues, published in the American Journal of Psychiatry in 2026, compared conventional scalp-based targeting with two connectivity-guided targeting approaches during an accelerated course of intermittent theta burst stimulation in adults with depression. Both connectivity-guided groups showed greater improvement than the conventional group at six weeks, although differences between groups were no longer significant by twelve weeks. This is one single-center trial, and its findings are a reason for careful optimism rather than a promise of a specific outcome.
Theta Burst Stimulation
Many accelerated protocols use intermittent theta burst stimulation, a pattern that delivers stimulation in a few minutes rather than the longer duration of conventional sessions. In the THREE-D randomized trial published in The Lancet in 2018, Blumberger and colleagues found that intermittent theta burst stimulation was non-inferior to standard high-frequency repetitive TMS for depression, with similar safety and tolerability, while requiring far shorter sessions.
Questions to Ask About Targeting
A consultation is an opportunity to understand exactly how your treatment location would be chosen.
Which Targeting Method Do You Recommend for Me, and Why?
Ask how the practice decides between scalp-based measurement, 3D-guided mapping, and fcMRI guidance. The answer should consider your diagnosis, treatment history, preferences, and any reasons an MRI may not be suitable. At NeoPsych, all three options are available, and Dr. Hughes explains the trade-offs of each.
Who Reviews the Imaging?
If an MRI is part of the plan, it is reasonable to ask who analyzes the images and identifies the target. At NeoPsych, each fcMRI reading is performed by a highly trained neuroscientist.
How Is the Target Reproduced at Each Session?
A precise target is most useful when it can be found again reliably. Ask how the coil is positioned at follow-up sessions. Our Accelerated TMS page describes how the first session establishes the treatment location and how later sessions return the coil to that same location without repeating the full mapping.
Questions to Ask About Protocol and Schedule
Targeting is one decision. The protocol and schedule are another, and they should fit both clinical needs and daily life.
Standard or Accelerated?
A standard course typically involves sessions five days a week over several weeks, as described on our TMS Therapy Overview. Accelerated options at NeoPsych include the 5-Day fcMRI-guided protocol, which delivers ten brief intermittent theta burst sessions each day over five consecutive days with rest between sessions, and the 10-Day protocol, which spreads fifty sessions across two weeks with five sessions per weekday for those who prefer a more gradual pace. The ONE-D protocol is a single-day approach that pairs accelerated stimulation with medications intended to support neuroplasticity.
Is the Protocol FDA Approved?
This is an important question. TMS for major depressive disorder is FDA cleared, but some accelerated schedules are performed off-label. NeoPsych states clearly on its protocol pages that the 5-Day fcMRI protocol, the 10-Day protocol, and the ONE-D protocol are not FDA approved. Understanding this helps people make informed decisions and have realistic conversations about insurance coverage.
What Will My Days Look Like?
Accelerated schedules involve multiple sessions each day with intervals in between. Ask about arrival times, how long you will be at the office, and how breaks are spent, so you can plan for work, family, and transportation. Our Accelerated TMS page notes that, between sessions, people usually stay on site and simply relax for the interval before the next appointment. Knowing this ahead of time makes it easier to bring a book, arrange time away from work, or plan for someone to drive you if you prefer. For the 10-Day protocol, the slower rhythm of five sessions per weekday leaves more room between treatments, which some people find easier to balance with other obligations.
Questions to Ask About Safety and Fit
Am I an Appropriate Candidate?
Every protocol requires an evaluation. Dr. Hughes reviews medical history, current symptoms, and past treatments to determine whether TMS is appropriate. Screening includes factors such as seizure risk, metal implants near the treatment area, and pregnancy, and the evaluation considers how TMS would fit with current medications.
What Side Effects Should I Expect?
Our protocol pages describe common side effects such as mild headache or scalp tenderness, which usually resolve quickly. Accelerated schedules involve more sessions in a shorter time, and some people notice increased scalp discomfort or fatigue. Ask how side effects are monitored and managed during treatment. During accelerated courses, a brief check-in at each visit to discuss side effects and benefits is part of the routine described on our Accelerated TMS page. If discomfort occurs, adjustments can be discussed with the treating team rather than simply tolerated, and any new or unusual symptom should be reported promptly.
How Does TMS Fit With My Medications and Therapy?
Dr. Hughes emphasizes conservative medication management and works with a referral network of therapists. Ask how your current medications will be handled during and after TMS, and whether therapy referrals are recommended.
Questions to Ask About Follow-Up
How Will Progress Be Measured?
Ask which symptom scales or check-ins will be used before, during, and after treatment. Consistent measurement makes it easier to see change over time. It can also help to ask whether family members or a partner are welcome to share observations, since the people closest to you sometimes notice changes in energy, engagement, or sleep before you do. Agreeing on a measurement plan in advance turns follow-up visits into focused conversations about specific changes rather than general impressions.
What Happens After the Course Ends?
Our FAQ explains that NeoPsych provides follow-up appointments to track progress and adjust the treatment plan, that support includes symptom monitoring and medication adjustments if applicable, and that maintenance TMS sessions may be offered to help prevent relapse. Knowing this plan before treatment begins helps set clear expectations.
Preparing for Your Consultation
A little preparation can make a consultation more productive. Consider writing down the medications you have tried for depression, approximate doses and durations, and whether each helped or caused side effects. Note any past experiences with psychotherapy, previous TMS, or other treatments, along with relevant medical history such as seizures, head injuries, or implanted devices. If you have had a brain MRI before, mention it. NeoPsych asks new patients to complete an online social and medical questionnaire, and the more detail it contains, the better the team can understand your needs and goals.
It is also helpful to think about your priorities. Some people value the shortest possible schedule. Others prefer a gradual pace, wish to avoid an MRI, or want to understand insurance considerations before choosing. There is no single right answer, and sharing these priorities openly allows Dr. Hughes to recommend an approach that balances clinical considerations with the realities of your life. Bringing a trusted person to the appointment, or having them join by telehealth, can also help you remember details and feel supported as you weigh the options.
Personalized Planning at NeoPsych
NeoPsych was founded by Dr. Thomas Hughes, a psychiatrist trained at the University of Miami Miller School of Medicine, the University of Southern California, and the University of Maryland and Sheppard Pratt. You can learn more about him on our Meet Dr. Hughes page. Our practice offers standard TMS, accelerated options, a choice of targeting methods including fcMRI guidance, conservative medication management, and lab reviews with genetic testing, with direct access to your provider and in-person and telehealth visits.
If you are exploring MRI-guided TMS in Los Angeles County, we invite you to bring your questions to a discovery call. NeoPsych serves Glendale, Burbank, Pasadena, and the surrounding communities. Visit our contact page to begin the conversation with our team.
References
Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry. 2012;72(7):595-603. https://pubmed.ncbi.nlm.nih.gov/22658708/
Li M, Wu Z, Lu X, Zalesky A, et al. Individualized connectivity-guided versus conventional targeting of accelerated theta-burst stimulation in depression: a randomized, double-blind, parallel-design trial. Am J Psychiatry. 2026;183(10):775-784. https://pubmed.ncbi.nlm.nih.gov/42581396/
Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet. 2018;391(10131):1683-1692. https://pubmed.ncbi.nlm.nih.gov/29726344/